[Immunotherapy and infectious issues in multiple sclerosis : Self-injectable and oral drugs for immunotherapy].

This article gives a detailed review of drug-specific red flags and current recommendations for the prophylaxis of infections associated with treatment of relapsing-remitting MS and when using self-injectable and oral disease-modifying immunotherapeutic drugs.
PMID: 26187544 [PubMed - as supplied by publisher]

Source: Der Nervenarzt - July 19, 2015 Category: Neurology Authors: Winkelmann A, Löbermann M, Reisinger EC, Hartung HP, Zettl UK Tags: Nervenarzt Source Type: research